MediSwipe, Inc. Announces Expansion of Corporate Headquarters in Colorado to Include Oncology Clinical Trial Partner & Testin...
April 11 2014 - 9:00AM
Marketwired
MediSwipe, Inc. Announces Expansion of Corporate Headquarters in
Colorado to Include Oncology Clinical Trial Partner and Testing
Facility
LOS ANGELES,
CA--(Marketwired - April 11, 2014) - MediSwipe,
Inc. (www.MediSwipe.com) (OTCQB:
MWIP), a fully reporting company on the OTCQB, a leader in
Compassionate Care Technology and indoor/outdoor agricultural
solutions for the medicinal marijuana industry, today announced
that the Company has expanded its corporate presence in Denver,
Colorado to now include 7,500 sq. ft. of office space for a
multi-year term. The new offices located within the Cherry Creek
subdivision and office complex will include sharing the space with
an established, Colorado based oncology clinical trial and drug
testing company and facility presently doing cancer research and
testing for established pharmaceutical companies seeking FDA
approval for new drugs.
"We have obviously begun to make a substantial commitment and
investment within the state of Colorado with our previously
announced agreements for ownership interests of approximately
one-hundred and sixty acres zoned for agricultural use and the
build out of our two managed green house facilities. It was
quite opportunistic for us to find this amount of executive office
space cost effectively which will allow us to expand our onsite
management and sales team beginning this month. At the same time,
we have found a potential synergistic partner within the oncology
and pharmaceutical testing side that could provide a value added
service to our clients and patients," stated B. Michael Friedman,
CEO of MediSwipe.
"We believe the testing facility could create an extremely
valuable vertical service by giving our tenants from the green
house farms the ability to test harvests providing insightful data
on THC and CBD levels of medicine once proper licensing by the
state is granted to our partners as a private, licensed Colorado
based testing facility. MediSwipe could provide the ability to
store all results and analytical data on our cloud based system on
behalf of the testing facility, tracking the quality and
consistency of medicine and provide documented data of patient
progress from multiple strains both THC and CBD specific on behalf
of the state licensed facility once approved," added Friedman.
About MediSwipe, Inc.
MediSwipe, Inc. (www.MediSwipe.com), the first fully reporting
Company and pioneer within the medicinal marijuana space, provides
innovative patient and agricultural solutions seeks to be the
leader in Compassionate Care Technology for the medicinal marijuana
industry. MediSwipe provides real estate management and health and
wellness product lines including beverages, vaporizers and
accessories. MediSwipe does not directly grow, harvest, or
distribute or sell cannabis or any substances that violate United
States law or the Controlled Substances Act, nor does it intend to
do so in the future.
FORWARD-LOOKING DISCLAIMER:
This press release may contain certain forward-looking
statements and information, as defined within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, and is subject to the Safe Harbor
created by those sections. This material contains statements about
expected future events and/or financial results that are
forward-looking in nature and subject to risks and uncertainties.
Such forward-looking statements by definition involve risks,
uncertainties and other factors, which may cause the actual
results, performance or achievements of MediSwipe, Inc. to be
materially different from the statements made herein.
Contact: MediSwipe,
Inc. 561.514.9042www.MediSwipe.cominfo@mediSwipe.com
Agritek (CE) (USOTC:AGTK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agritek (CE) (USOTC:AGTK)
Historical Stock Chart
From Apr 2023 to Apr 2024